Imax Corp. diskutieren
Imax Corp.
WKN: 896801 / Symbol: IMAX / Name: IMAX / Aktie / Hotels & Unterhaltung / Small Cap /
32,40 €
0,62 %
IMAX (NYSE:IMAX) had its price target raised by analysts at Wedbush from $35.00 to $39.00. They now have an "outperform" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its price target raised by analysts at Rosenblatt Securities from $37.00 to $42.00. They now have a "buy" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its "buy" rating reaffirmed by analysts at B. Riley.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) was given a new $40.00 price target on by analysts at Roth Capital. They now have a "buy" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its "buy" rating reaffirmed by analysts at Rosenblatt Securities. They now have a $42.00 price target on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its price target raised by analysts at Wells Fargo & Company from $34.00 to $40.00. They now have an "overweight" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its price target raised by analysts at Rosenblatt Securities from $42.00 to $47.00. They now have a "buy" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its price target raised by analysts at Barrington Research from $37.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its price target raised by analysts at Benchmark Co. from $40.00 to $42.00. They now have a "buy" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its price target raised by analysts at Wedbush from $39.00 to $46.00. They now have an "outperform" rating on the stock.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its "buy" rating reaffirmed by analysts at B. Riley.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) had its "buy" rating reaffirmed by analysts at Roth Capital.
Ratings data for IMAX provided by MarketBeat
IMAX (NYSE:IMAX) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $47.00 price target on the stock, up previously from $32.00.
Ratings data for IMAX provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Biocryst Pharmaceuticals diskutieren